Thermo Fisher Scientific (TMO) Other Working Capital Changes (2009 - 2020)

Thermo Fisher Scientific has disclosed Other Working Capital Changes across 12 years of filings, most recently posting -$410.0 million for Q4 2020.

• Quarterly Other Working Capital Changes fell 322.83% year-over-year to -$410.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$1.5 billion (down 833.33% YoY) and the FY2025 annual result came in at $1.3 billion, up 605.38% from the prior year.
• Other Working Capital Changes advanced to -$410.0 million in Q4 2020, from -$739.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $443.0 million in Q1 2020 and troughed at -$746.0 million in Q2 2020.
• A 5-year average of -$48.0 million and a median of $45.4 million in 2016 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2017 — Other Working Capital Changes surged 697.1% — and 2019, when it slumped 985.45%.
• Tracing TMO's Other Working Capital Changes over 5 years: stood at $60.7 million in 2016, then slumped by 231.8% to -$80.0 million in 2017, then slumped by 146.25% to -$197.0 million in 2018, then jumped by 193.4% to $184.0 million in 2019, then plunged by 322.83% to -$410.0 million in 2020.
• Business Quant data shows TMO's Other Working Capital Changes at -$410.0 million in Q4 2020, -$739.0 million in Q3 2020, and -$746.0 million in Q2 2020.